scholarly journals Does cardiovascular risk reduction alleviate erectile dysfunction in men with type II diabetes mellitus?

2008 ◽  
Vol 20 (5) ◽  
pp. 501-506 ◽  
Author(s):  
S A M Khatana ◽  
T H Taveira ◽  
M M Miner ◽  
C B Eaton ◽  
W-C Wu
Keyword(s):  
Diabetes Mellitus ◽  
Erectile Dysfunction ◽  
Cardiovascular Risk ◽  
Risk Reduction ◽  
Type Ii Diabetes ◽  
Type Ii Diabetes Mellitus ◽  
Type Ii ◽  
Cardiovascular Risk Reduction

scholarly journals Coronary Heart Disease in Postmenopausal Women with Type II Diabetes Mellitus and the Impact of Estrogen Replacement Therapy: A Narrative Review

2014 ◽  
Vol 2014 ◽  
pp. 1-8 ◽  
Author(s):  
Marouane Boukhris ◽  
Salvatore Davide Tomasello ◽  
Francesco Marzà ◽  
Sonia Bregante ◽  
Francesca Romana Pluchinotta ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Coronary Heart Disease ◽  
Heart Disease ◽  
Cardiovascular Risk ◽  
Type Ii Diabetes ◽  
Estrogen Replacement Therapy ◽  
Type Ii Diabetes Mellitus ◽  
Type Ii ◽  
Estrogen Replacement ◽  
The Impact

Coronary heart disease is the main cause of death in postmenopausal women (PMW); moreover its mortality exceeds those for breast cancer in women at all ages. Type II diabetes mellitus is a major cardiovascular risk factor and there is some evidence that the risk conferred by diabetes is greater in women than in men. It was established that the deficiency of endogenous estrogens promotes the atherosclerosis process. However, the impact of estrogen replacement therapy (ERT) on cardiovascular prevention remains controversial. Some authors strongly recommend it, whereas others revealed a concerning trend toward harm. This review tries to underlines the different components of cardiovascular risk in diabetic PMW and to define the place of ERT.

scholarly journals Sildenafil citrate for the treatment of erectile dysfunction in men with Type II diabetes mellitus

Diabetologia ◽  
2001 ◽  
Vol 44 (10) ◽  
pp. 1296-1301 ◽  
Author(s):  
A. J. M. Boulton ◽  
J.-L. Selam ◽  
M. Sweeney ◽  
D. Ziegler
Keyword(s):  
Diabetes Mellitus ◽  
Erectile Dysfunction ◽  
Type Ii Diabetes ◽  
Type Ii Diabetes Mellitus ◽  
Sildenafil Citrate ◽  
Type Ii

Association between sarcopenia and erectile dysfunction in males with type II diabetes mellitus

2018 ◽  
Vol 22 (1) ◽  
pp. 20-27 ◽  
Author(s):  
Sema Uçak ◽  
Rıdvan Sivritepe ◽  
Oğuzhan Kara ◽  
Ecem Sevim ◽  
Damla Ortaboz ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Erectile Dysfunction ◽  
Type Ii Diabetes ◽  
Type Ii Diabetes Mellitus ◽  
Type Ii

scholarly journals Prevalence and Determinant of Erectile Dysfunction in Type II Diabetes Mellitus and Healthy Men

2021 ◽  
Vol 3 (1) ◽  
pp. 23-34
Author(s):  
Dorcas Serwaa ◽  
Folasade Adenike Bello ◽  
Kayode O. Osungbade ◽  
Charles Nkansah
Keyword(s):  
Quality Of Life ◽  
Diabetes Mellitus ◽  
Logistic Regression ◽  
Erectile Dysfunction ◽  
Type Ii Diabetes ◽  
Type Ii Diabetes Mellitus ◽  
Type Ii ◽  
Healthy Men ◽  
Study Participants

Erectile dysfunction is currently a growing health concern and one of the most prevalent sexual dysfunctions in men worldwide. Diabetes mellitus is considered a risk factor for developing ED. Therefore, this SHIM study was designed to assess the prevalence, severity and determinant of erectile dysfunction in type II diabetes mellitus patients and healthy men. This hospital-based cross-sectional study was conducted on 132 diabetic male patients and 66 healthy men at the Nkenkaasu hospital, Offinso North, Ghana between January-June, 2019. A pre-structured questionnaire and patients’ medical records were used to document relevant information. Erectile function was assessed using Sexual health inventory for men questionnaire. Data were analyzed using SPSS version 22.0. Chi-square test, binary and multivariable logistic regression analysis were used appropriately. The mean age of study participants was 57.94 ± 9.79 years. The overall mean score on the SHIM test was 12.42 ± 8.15 (range: 1–25), mean of 9.59±7.83 for the type II diabetics and 18.08±5.39 for non-diabetic men. The total erectile dysfunction (ED) prevalence was 81.8% (95% CI: 0.757, 0.869). ED was common in diabetics (70.4%) compared with healthy men (29.6%). Severe ED was 93.7% and 6.3% in the diabetic and non-diabetic men respectively. Multivariate logistic regression revealed that diabetic men with poor health-related quality of life had 3.48 times likelihood of having ED compared to their non-diabetic counterparts (AOR= 3.48, 95% CI; 1.284, 9.453). Very high erectile dysfunction was observed in our study participants. This is worrisome owing to the profound negative impact of ED on the quality of life and fertility of men. It is recommended that periodic assessment of erectile function should form part of routine diabetes care, focusing attention on the modifiable risk factors in preventing, delaying progression, or reversing established ED in persons. Doi: 10.28991/SciMedJ-2021-0301-4 Full Text: PDF

Sign in / Sign up

Export Citation Format

Share Document